Cambridge, MA, United States of America

Spero Therapeutics, Inc.

Calculating rank
USPTO Granted Patents = 8



Forward Citations = 2

Loading Chart...
Loading Chart...

23 inventors (with patents filed for the assignee):

goldMedal Akash Jain (5 out of 14 patents)

silverMedal Richard Edwards (3 out of 16 patents)

bronzeMedal Evan Hecker (3 out of 6 patents)

4.  Thierry Bonnaud (3 out of 14 patents)

5.  Pamela Brown (3 out of 4 patents)

6.  Michael Dawson (3 out of 4 patents)

7.  Mona Simonovic (3 out of 4 patents)

8.  Steven Boakes (3 out of 4 patents)

9.  Esther Duperchy (3 out of 4 patents)

10.  Dean Rivers (2 out of 2 patents)

11.  Roy Lester (2 out of 2 patents)

12.  Scott Coleman (2 out of 2 patents)

13.  Shaoqiong Lyu (1 out of 5 patents)

14.  Shoufeng Li (1 out of 13 patents)

15.  Stephen Frederick Moss (1 out of 14 patents)


8 patents:

Company Overview
Spero Therapeutics, Inc. is a biopharmaceutical company focused on developing novel treatments for bacterial infections. Their mission is to combat drug-resistant bacteria and improve patient outcomes. Spero Therapeutics is dedicated to advancing their pipeline of antibiotics to address critical unmet medical needs in the global healthcare market.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

8 Patents

#275 in Cambridge, MA

#2,102 in Massachusetts

#35,954 in US

Cambridge, MA (US)
Cambridge, MA, United States of America
Forward Citations = 2

23 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Spero Therapeutics, Inc.. Retrieved from https://idiyas.com/company/spero-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…